Cargando…

Impaired Duodenal Palmitoylethanolamide Release Underlies Acid-Induced Mast Cell Activation in Functional Dyspepsia

BACKGROUND & AIMS: Acid hypersensitivity is claimed to be a symptomatic trigger in functional dyspepsia (FD); however, the neuroimmune pathway(s) and the mediators involved in this process have not been investigated systematically. Palmitoylethanolamide (PEA) is an endogenous compound, able to m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarnelli, Giovanni, Pesce, Marcella, Seguella, Luisa, Lu, Jie, Efficie, Eleonora, Tack, Jan, Elisa De Palma, Fatima Domenica, D’Alessandro, Alessandra, Esposito, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858681/ https://www.ncbi.nlm.nih.gov/pubmed/33065341 http://dx.doi.org/10.1016/j.jcmgh.2020.10.001

Ejemplares similares

Engineered Lactobacillus paracasei Producing Palmitoylethanolamide (PEA) Prevents Colitis in Mice
por: Esposito, Giuseppe, et al.
Publicado: (2021)

HIV-1 Tat-induced diarrhea is improved by the PPARalpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia
por: Sarnelli, Giovanni, et al.
Publicado: (2018)

Oral Adelmidrol Administration Up-Regulates Palmitoylethanolamide Production in Mice Colon and Duodenum through a PPAR-γ Independent Action
por: Del Re, Alessandro, et al.
Publicado: (2022)

A Palmitoylethanolamide Producing Lactobacillus paracasei Improves Clostridium difficile Toxin A-Induced Colitis
por: Esposito, Giuseppe, et al.
Publicado: (2021)

Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner
por: Sarnelli, Giovanni, et al.
Publicado: (2016)

Ultramicronized Palmitoylethanolamide Inhibits NLRP3 Inflammasome Expression and Pro-Inflammatory Response Activated by SARS-CoV-2 Spike Protein in Cultured Murine Alveolar Macrophages
por: Del Re, Alessandro, et al.
Publicado: (2021)

Sleeve Gastrectomy-Induced Body Mass Index Reduction Increases the Intensity of Taste Perception’s and Reduces Bitter-Induced Pleasantness in Severe Obesity
por: Rurgo, Sara, et al.
Publicado: (2022)

Endocannabinoid‐related compounds in gastrointestinal diseases
por: Pesce, Marcella, et al.
Publicado: (2017)

S100B Protein Stimulates Proliferation and Angiogenic Mediators Release through RAGE/pAkt/mTOR Pathway in Human Colon Adenocarcinoma Caco-2 Cells
por: Seguella, Luisa, et al.
Publicado: (2019)

Can the enteric nervous system be an alternative entrance door in SARS-CoV2 neuroinvasion?
por: Esposito, Giuseppe, et al.
Publicado: (2020)

Duodenal Implications in the Pathophysiology of Functional Dyspepsia
por: Lee, Kwang Jae, et al.
Publicado: (2010)

High-fat diet impairs duodenal barrier function and elicits glia-dependent changes along the gut-brain axis that are required for anxiogenic and depressive-like behaviors
por: Seguella, Luisa, et al.
Publicado: (2021)

The potential of cannabidiol in the COVID‐19 pandemic
por: Esposito, Giuseppe, et al.
Publicado: (2020)

Oral Immunization with Escherichia coli Nissle 1917 Expressing SARS-CoV-2 Spike Protein Induces Mucosal and Systemic Antibody Responses in Mice
por: Sarnelli, Giovanni, et al.
Publicado: (2023)

Rifaximin Improves Clostridium difficile Toxin A-Induced Toxicity in Caco-2 Cells by the PXR-Dependent TLR4/MyD88/NF-κB Pathway
por: Esposito, Giuseppe, et al.
Publicado: (2016)

Leaky gut, dysbiosis, and enteric glia activation: the trilogy behind the intestinal origin of Parkinson’s disease
por: Seguella, Luisa, et al.
Publicado: (2019)

HIV-1 Tat-induced diarrhea evokes an enteric glia-dependent neuroinflammatory response in the central nervous system
por: Esposito, Giuseppe, et al.
Publicado: (2017)

Diet and functional dyspepsia: Clinical correlates and therapeutic perspectives
por: Pesce, Marcella, et al.
Publicado: (2020)

Differences in Duodenal Mast Cell and Eosinophil Counts Between Patients With Functional Dyspepsia and Healthy People
por: Hayatbakhsh Abbasi, Mohammad Mahdi, et al.
Publicado: (2021)

Activation of Eosinophils and Mast Cells in Functional Dyspepsia: an Ultrastructural Evaluation
por: Vanheel, Hanne, et al.
Publicado: (2018)

Cannabidiol inhibits SARS‐Cov‐2 spike (S) protein‐induced cytotoxicity and inflammation through a PPARγ‐dependent TLR4/NLRP3/Caspase‐1 signaling suppression in Caco‐2 cell line
por: Corpetti, Chiara, et al.
Publicado: (2021)

Next-Generation Probiotics for Inflammatory Bowel Disease
por: Pesce, Marcella, et al.
Publicado: (2022)

N-Palmitoyl-D-Glucosamine Inhibits TLR-4/NLRP3 and Improves DNBS-Induced Colon Inflammation through a PPAR-α-Dependent Mechanism
por: Palenca, Irene, et al.
Publicado: (2022)

The Gastric and Duodenal Eosinophilia in Functional Dyspepsia
por: Kim, Hyun Jin
Publicado: (2016)

Role of the duodenal microbiota in functional dyspepsia
por: Brown, Georgia, et al.
Publicado: (2022)

Duodenal Dysbiosis and Relation to the Efficacy of Proton Pump Inhibitors in Functional Dyspepsia
por: Wauters, Lucas, et al.
Publicado: (2021)

The Bitter Taste Receptor Agonist Quinine Reduces Calorie Intake and Increases the Postprandial Release of Cholecystokinin in Healthy Subjects
por: Andreozzi, Paolo, et al.
Publicado: (2015)

Nutraceuticals and Diet Supplements in Crohn’s Disease: A General Overview of the Most Promising Approaches in the Clinic
por: De Conno, Barbara, et al.
Publicado: (2022)

Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats
por: De Filippis, Daniele, et al.
Publicado: (2011)

Pentamidine niosomes thwart S100B effects in human colon carcinoma biopsies favouring wtp53 rescue
por: Seguella, Luisa, et al.
Publicado: (2020)

High degree of duodenal inflammation in Nigerians with functional dyspepsia
por: Nwokediuko, Sylvester Chuks, et al.
Publicado: (2013)

Gastric corticotropin-releasing factor influences mast cell infiltration in a rat model of functional dyspepsia
por: Hagiwara, Shin-ichiro, et al.
Publicado: (2018)

Palmitoylethanolamide Inhibits Glutamate Release in Rat Cerebrocortical Nerve Terminals
por: Lin, Tzu-Yu, et al.
Publicado: (2015)

Endoscopy-Guided Evaluation of Duodenal Mucosal Permeability in Functional Dyspepsia
por: Ishigami, Hideaki, et al.
Publicado: (2017)

Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity
por: Petrosino, Stefania, et al.
Publicado: (2019)

Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain
por: Impellizzeri, Daniela, et al.
Publicado: (2014)

Erratum to: Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain
por: Impellizzeri, Daniela, et al.
Publicado: (2016)

The Basal Pharmacology of Palmitoylethanolamide
por: Rankin, Linda, et al.
Publicado: (2020)

Neuroprotective Activities of Palmitoylethanolamide in an Animal Model of Parkinson's Disease
por: Esposito, Emanuela, et al.
Publicado: (2012)

Increased Duodenal Eosinophil Degranulation in Patients with Functional Dyspepsia: A Prospective Study
por: Du, Lijun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l7kf7v59hm5hb5ua8cgkrln3uu